BusinessAdmera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology ProductsBy Nasdaq OMXOct 31, 2017, 1:13 PM UTC
BusinessAdmera Health Expands Asian Footprint with Three Strategic PartnershipsBy Nasdaq OMXSep 12, 2017, 3:05 PM UTC
BusinessColumbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric MedicationsBy Nasdaq OMXJul 25, 2017, 11:00 PM UTC
BusinessAdmera Health Partners with Helix to Launch Genetic Tests to Assess the Risk of Inherited High Cholesterol, Sudden Cardiac Death, and Inherited DiabetesBy Nasdaq OMXJul 24, 2017, 11:45 AM UTC
BusinessHealth in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic CardiomyopathiesBy Nasdaq OMXMay 3, 2017, 1:13 PM UTC
